Skip to content
Wenlo
Sign in
← Markets

Gilead Sciences Inc.

Gilead Sciences Inc. (GILD) — Form 144: Proposed sale of shares

144GILDFiled Nov 4, 2026, 4:30 PM ET

AI-generated summary

Director and Officer Daniel O'Day of Gilead Sciences Inc. proposed to sell 112,429 common shares with an aggregate market value of $18,828,484.63 through Morgan Stanley Smith Barney LLC Executive Financial Services. The shares are to be acquired via the exercise of stock options on November 4, 2026. The proposed sale is associated with a trading plan adopted on February 25, 2026.

View original filing on SEC.gov (opens SEC EDGAR)

Key facts

Seller
DANIEL O'DAY
Relationship
Director, Officer
Shares to sell
112,429
Market value
$18,828,484.63
Approximate sale date
Nov 4, 2026
Broker
Morgan Stanley Smith Barney LLC Executive Financial Services
Acquired
Nov 4, 2026 · Exercise of Stock Options

Rule 10b5-1 plan · adopted Feb 25, 2026

Remarks
  1. The securities to be sold were and will be received upon the exercise of stock options over the next three months. The dates of acquisition and payment were and will be the dates of exercise/sale.

More GILD filings

Not investment advice. Summaries can contain errors; the SEC filing is the official record.